Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy
2015 ◽
Vol 41
(7)
◽
pp. 649-661
◽
2012 ◽
Vol 35
(11)
◽
pp. 1279-1289
◽
2013 ◽
Vol 38
(2)
◽
pp. 107-117
◽
2013 ◽
Vol 39
(1)
◽
pp. 47-56
◽
2011 ◽
Vol 33
(8)
◽
pp. 911-921
◽
2009 ◽
Vol 5
(1)
◽
pp. 32-37
◽
2010 ◽
Vol 32
(2)
◽
pp. 182-190
◽
Keyword(s):